Formycon AGHAM:FYB +3.83%60 Days Inventory is 15.95 as of Dec. 2025, which is 105% above its 10-year median of 7.78. GuruFocus rates HAM:FYB with a GF Score™ of 60/100 and a GF Value™ of €37.20 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 638 Biotechnology companies, Formycon AG ranks better than 97.49% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Formycon AG's Average Total Inventories for the
six
months ended in Dec. 2025 was €1.61 Mil. Formycon AG's Cost of Goods Sold for the
six
months ended in Dec. 2025 was €18.46 Mil.
Hence, Formycon AG's Days Inventory for the
six
months ended in Dec. 2025 was 15.95.
The historical rank and industry rank for Formycon AG's Days Inventory or its related term are showing as below:
HAM:FYB'
s Days Inventory Range Over the Past 10 Years
Min: 2.43 Med: 7.78 Max: 13.21
Current: 10.38
During the past 13 years, Formycon AG's highest Days Inventory was 13.21. The lowest was 2.43. And the median was 7.78.
HAM:FYB's Days Inventory is ranked better than 97.49% of 638
companies
in the Biotechnology industry
Industry Median: 183.195
vs HAM:FYB: 10.38
Formycon AG's Days Inventory
increased
from Dec. 2024 (7.29) to Dec. 2025 (15.95).
It might indicate that Formycon AG's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Formycon AG's Inventory Turnover for the
six
months ended in Dec. 2025 was 11.44.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Formycon AG's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.05.
Formycon AG (HAM:FYB) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Formycon AG's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Formycon AG's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Formycon AG Days Inventory Related Terms
Formycon AG Days Inventory Historical Data
* Premium members only.
The historical data trend for Formycon AG's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HAM:FYB vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Formycon AG's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Formycon AG Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Formycon AG's Days Inventory distribution charts can be found below:
* The bar in red indicates where Formycon AG's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Formycon AG (HAM:FYB) has a Days Inventory of 15.95 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Formycon AG and its competitors. This is 105% above median its historical median of 7.78. Over the past decade, Formycon AG's Days Inventory has ranged from 2.43 to 13.21. According to the industry distribution chart, Formycon AG ranks #16 out of 638 companies in the Biotechnology industry, placing it in the top 2.5%.
Is Formycon AG's Days Inventory too high?
Formycon AG's current Days Inventory of 15.95 is 105% above median its 10-year median of 7.78. Over the past 10 years, this metric has ranged from a low of 2.43 to a high of 13.21. The Biotechnology industry median Days Inventory is 183.20. Formycon AG's value of 15.95 is 91.3% below this industry median. Based on the distribution chart, Formycon AG ranks #16 out of 638 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Formycon AG has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Formycon AG's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Formycon AG ranks #16 out of 638 companies for Days Inventory. This places Formycon AG in the top 3% of its industry — outperforming the majority of peers. The industry median Days Inventory is 183.20. Formycon AG's value of 15.95 is 91.3% below this benchmark. Historically, Formycon AG's own Days Inventory has ranged from 2.43 to 13.21 over the past decade. While the company's 10-year median is 7.78 vs. the industry median of 183.20, Formycon AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Formycon AG's current Days Inventory of 15.95 is 91.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Formycon AG and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Formycon AG's current Days Inventory is 15.95, which is 105% above median its own 10-year median of 7.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Formycon AG stock overvalued right now?
Based on GuruFocus' analysis, Formycon AG (HAM:FYB) is currently considered Possible Value Trap. The stock's GF Value™ is €37.20, compared to a current price of €18.98 — trading 49% below its estimated fair value. The current Days Inventory is 15.95, which is 105% above median its 10-year median of 7.78 and 91.3% below the Biotechnology industry median of 183.20. Formycon AG's overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Formycon AG (HAM:FYB), the current Days Inventory is 15.95 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Formycon AG (HAM:FYB) Overvalued in 2026?
Based on GuruFocus' analysis, Formycon AG stock appears to be undervalued.
The current stock price of €18.98 is trading 49% below its estimated GF Value™ of €37.20.
GuruFocus considers Formycon AG to be Possible Value Trap.
Key valuation signals for HAM:FYB:
Days Inventory: 15.95 (105% above median its 10-year median of 7.78)
GF Value™: €37.20 vs. price of €18.98 (49% below fair value)
Industry Position: 91.3% below the Biotechnology median (#16 of 638)
No single metric tells the full story. See the HAM:FYB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Formycon AG is an independent developer of high-quality biosimilars, which are follow-on products to biopharmaceutical drugs. The Company focuses on expanding and further developing its scalable biosimilar platform, which includes approved and pipeline products across ophthalmology, immunology, and immuno-oncology. Its key products include FYB201 (ranibizumab), FYB202 (ustekinumab), FYB203 (aflibercept), FYB206 (pembrolizumab), and FYB208 (dupilumab), along with additional biosimilar candidates in various stages of development. The Company generates maximum revenue from Switzerland.
60GF Score
Get the complete analysis for HAM:FYB
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAM:FYB has been successfully added to your 
